基本信息

来源摘要/节选

公开展示已截断至最多 800 个字符；请访问原始来源查看完整上下文。

In precision medicine, researchers developing diagnostic tests for early disease detection face a critical challenge: datasets containing thousands of potential biomarkers but only hundreds of patient samples. This curse of dimensionality can determine the success or failure of breakthrough discoveries.

Modern bioinformatics use multiple omic modalities—genomics, lipidomics, proteomics, and metabolomics—to develop early disease detection tests. Researchers in this industry are also often challenged with datasets where features outnumber samples by orders of magnitude. As new modalities are considered, the permutations increase exponentially, making experiment tracking a significant challenge.…

来源说明

当前只保存了公开页面节选，不代表原文全文。请以原始来源为准。

本页只呈现已做哈希绑定的来源证据，不包含基于旧正文或缺失原文的扩展推断。